Indaptus Therapeutics Dividends and Buybacks
Dividend criteria checks 0/6
Indaptus Therapeutics does not have a record of paying a dividend.
Key information
n/a
Dividend yield
-33.1%
Buyback Yield
| Total Shareholder Yield | -33.1% |
| Future Dividend Yield | n/a |
| Dividend Growth | n/a |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | n/a |
| Payout ratio | n/a |
Recent dividend and buyback updates
No updates
Recent updates
Is Indaptus Therapeutics (NASDAQ:INDP) In A Good Position To Invest In Growth?
Mar 27
Is Indaptus Therapeutics (NASDAQ:INDP) In A Good Position To Deliver On Growth Plans?
Aug 15Indaptus Therapeutics GAAP EPS of -$0.46 beats by $0.45
Aug 08Indaptus Therapeutics: Advancing Decoy Technology To Address Cancer And Viral Indications
Sep 29Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Insufficient data to determine if INDP's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if INDP's dividend payments have been increasing.
Dividend Yield vs Market
| Indaptus Therapeutics Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (INDP) | n/a |
| Market Bottom 25% (US) | 1.4% |
| Market Top 25% (US) | 4.2% |
| Industry Average (Biotechs) | 2.3% |
| Analyst forecast (INDP) (up to 3 years) | n/a |
Notable Dividend: Unable to evaluate INDP's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate INDP's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate INDP's payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as INDP has not reported any payouts.